Paasa Logo
JW Pharmaceutical Corporation logo
001060KRXMarket closedOpens 9:00am KST

JW Pharmaceutical Corporation

₩26,350.00Last updated
-₩1,300.00 (4.70%)Past day
Timezone

JW Pharmaceutical Corporation (KRX: 001060) is trading at ₩26,350.00, about ₹1,902 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 4.70% today. JW Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.

Quote

Open:₩27,550.00
Previous close:₩27,650.00
Volume:65.78K

Today's low

₩26,250.00

Today's high

₩27,550.00

52 week low

₩20,700.00

52 week high

₩39,250.00

001060 opened at ₩27,550.00, closed previously at ₩27,650.00, and has traded between ₩20,700.00 and ₩39,250.00 over the past 52 weeks.

About

JW Pharmaceutical Corporation, established in 1945 and headquartered in Seoul, South Korea, operates globally, focusing on the development, manufacturing, and distribution of a comprehensive range of pharmaceuticals and medical supplies. Its diverse product portfolio addresses numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and metabolic health, as well as infectious diseases, women's health, renal and central nervous system disorders, anti-anemic treatments, respiratory ailments, rheumatic arthritis, oncology, anesthesia, antidotes, and advanced nutritional support.

Country
KR
CEO
Young-Sub Shin
Exchange listed on
KRX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
KRW
Full Time Employees
1,106
Sector
Healthcare
IPO date
29/09/2005

Key statistics

Avg. volume

57.99K

Market cap

₩608.52B

P/E Ratio

6.28

Price-to-sales ratio

0.74

Enterprise value

₩631.02B

Free cash flow yield

13.75%

Debt-to-equity ratio

0.18

Return on equity

16.70%

ROIC

14.08%

Beta

0.96

Dividend yield

2.47%

Last dividend

₩650.00

Financial overview

Revenue

₩774.80B

Earnings per share

₩2,534.75

Free cash flow

₩84.62B

Net profit margin

12.35%

Gross margin

47.32%

EBITDA

₩106.62B

Revenue growth

7.70%

Similar securities

This is not an investment recommendation

JW Pharmaceutical for Indian investors

JW Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.

Taxes on JW Pharmaceutical for Indian residents

Trading and limits

Trading hours
9:00 am – 3:30 pm KST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. JW Pharmaceutical’s current yield is 2.47%.Dividend tax explained

FAQs

Can I buy JW Pharmaceutical on Paasa?

JW Pharmaceutical (001060) has been listed on the Korea Exchange since 2005, in the Drug Manufacturers - Specialty & Generic industry. JW Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.

How much does one JW Pharmaceutical share cost in rupees?

One JW Pharmaceutical share is ₩26,350.00 — about ₹1,902 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the JW Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for investing abroad from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.

How are gains on JW Pharmaceutical shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the JW Pharmaceutical price.

Does JW Pharmaceutical pay a dividend, and how is it taxed in India?

Yes. JW Pharmaceutical pays a dividend and the current yield is 2.47%; the last declared dividend was ₩650.00 per share, about ₹46.91. Dividends are taxed at your slab rate in India.

When does KRX trade, in Indian time?

The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.

Do I have to declare JW Pharmaceutical shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.

Does the rupee rate affect what I make on JW Pharmaceutical?

Yes. JW Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.